Arid3a regulates mesoderm differentiation in mouse embryonic stem cells

Main Article Content

Melissa Popowski
Bum-kyu Lee
Cathy Rhee
Vishwanath R Iyer
Haley O Tucker*

Abstract

Research into regulation of the differentiation of stem cells is critical to understanding early developmental decisions and later development growth. The transcription factor ARID3A previously was shown to be critical for trophectoderm and hematopoetic development. Expression of ARID3A increases during embryonic differentiation, but the underlying reason remained unclear. Here we show that Arid3a null embryonic stem (ES) cells maintain an undifferentiated gene expression pattern and form teratomas in immune-compromised mice. However, Arid3a null ES cells differentiated in vitro into embryoid bodies (EBs) significantly faster than control ES cells, and the majority forming large cystic embryoid EBs. Analysis of gene expression during this transition indicated that Arid3a nulls differentiated spontaneously into mesoderm and neuroectoderm lineages. While young ARID3A-deficient mice showed no gross tissue morphology, proliferative and structural abnormalities were observed in the kidneys of older null mice. Together these data suggest that ARID3A is not only required hematopoiesis, but is critical for early mesoderm differentiation.

Article Details

Popowski, M., Lee, B.- kyu, Rhee, C., R Iyer, V., & Tucker, H. O. (2017). Arid3a regulates mesoderm differentiation in mouse embryonic stem cells. Journal of Stem Cell Therapy and Transplantation, 1(1), 052–062. https://doi.org/10.29328/journal.jsctt.1001005
Research Articles

Copyright (c) 2017 Popowski M, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The Journal of Stem Cell Therapy and Transplantation is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.

License: Copyright © 2017 - 2025 | Creative Commons License Open Access by Journal of Stem Cell Therapy and Transplantation is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.

With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.

Compliance 'CC BY' license helps in:

Permission to read and download
Permission to display in a repository
Permission to translate
Commercial uses of manuscript

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license. 

Martello G, Smith A. The nature of embryonic stem cells. Annu Rev Cell Dev Biol. 2014; 30; 647-675. Ref.: https://goo.gl/2fQ2im

Hemberger M, Dean W, Reik W. Epigenetic dynamics of stem cells and cell lineage commitment: digging Waddington’s canal. Nat Rev Mol Cell Biol. 2009; 10; 526-537. Ref.: https://goo.gl/zmVgwx

Nixon JC, Ferrell S, Miner C, Oldham AL, Hochgeschwender U, et al. Transgenic mice expressing dominant-negative Arid3a exhibit defects in B1 B cells. J Immunol Baltim Md. 2008; 181; 6913-6922. Ref.: https://goo.gl/suWSPu

Webb CF, Bryant J, Popowski M, Allred L, Kim D, et al. The ARID family transcription factor Arid3a is required for both hematopoietic stem cell and B lineage development. Mol Cell Biol. 2011; 31; 1041-1053. Ref.: https://goo.gl/wGgErP

Kim PG, Canver MC, Rhee C, Ross SJ, Harriss JV, et al. Interferon-α signaling promotes embryonic HSC maturation. Blood. 2016; 128: 204-216. Ref.: https://goo.gl/nTGHsW

Rhee C, Edwards M, Dang C, Harris J, Brown M, et al. ARID3A is required for mammalian placenta development. Dev Biol. 2017; 422: 83-91. Ref.: https://goo.gl/Dq2rku

Rhee C, Lee BK, Beck S, Anjum A, Cook KR, Popowski M, et al. Corrigendum: Arid3a is essential to execution of the first cell fate decision via direct embryonic and extraembryonic transcriptional regulation. Genes Dev. 2015; 29: 1890. Ref.: https://goo.gl/aSTe3c

An G, Miner CA, Nixon JC, Kincade PW, Bryant J, et al. Loss of Arid3a/ARID3a function promotes developmental plasticity. Stem Cells Dayt Ohio. 2010; 28: 1560-1567. Ref.: https://goo.gl/NFFfUf

Popowski M, Templeton TD, Lee BK, Rhee C, Li H, et al. Arid3a/Arid3A Acts as a Barrier to Somatic Cell Reprogramming through Direct Regulation of Oct4, Sox2, and Nanog. Stem Cell Rep. 2014; 2: 26-35. Ref.: https://goo.gl/ZUgmtk

Wang J, Rao S, Chu J, Shen X, Levasseur DN, et al. A protein interaction network for pluripotency of embryonic stem cells. Nature. 2006; 444: 364-368. Ref.: https://goo.gl/aWnkHB

Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med. 2000; 6: 88-95. Ref.: https://goo.gl/Vrwepk

Kurosawa H. Methods for Inducing Embryoid Body Formation: In Vitro Differentiation System of Embryonic Stem Cells. J Biosci Bioeng. 2007; 103: 389-398. Ref.: https://goo.gl/YhYLHo

Wang R, Clark R, Bautch VL. Embryonic stem cell-derived cystic embryoid bodies form vascular channels: an in vitro model of blood vessel development. Dev Camb Engl. 1992; 114: 303-316. Ref.: https://goo.gl/daxwVF

Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol. 1985; 87: 27-45. Ref.: https://goo.gl/WKVyCQ

Yasuda E, Seki Y, Higuchi T, Nakashima F, Noda T, et al. Development of cystic embryoid bodies with visceral yolk-sac-like structures from mouse embryonic stem cells using low-adherence 96-well plate. J Biosci Bioeng. 2009; 107: 442-446. Ref.: https://goo.gl/a4Pi8d

Ng YS, Ramsauer M, Loureiro RMB, D’Amore PA. Identification of genes involved in VEGF-mediated vascular morphogenesis using embryonic stem cell-derived cystic embryoid bodies. Lab Invest. 2004; 84: 1209-1218. Ref.: https://goo.gl/6QALJf

Fuegemann CJ, Samraj AK, Walsh S, Fleischmann BK, Jovinge S, et al. Differentiation of Mouse Embryonic Stem Cells into Cardiomyocytes via the Hanging-Drop and Mass Culture Methods. Curr Protoc Stem Cell Biol. 2010. Ref.: https://goo.gl/fKxcSo

Kim D, Tucker PW. A regulated nucleocytoplasmic shuttle contributes to Arid3a’s function as a transcriptional activator of immunoglobulin genes. Mol Cell Biol. 2006; 26: 2187-2201. Ref.: https://goo.gl/JGdVXL

Schmidt C, Kim D, Ippolito GC, Naqvi HR, Probst L, et al. Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright. EMBO J. 2009; 28: 711-724. Ref.: https://goo.gl/9ehCcC

Ma K, Araki K, Ichwan SJ, Suganuma T, Tamamori-Adachi M, et al. E2FBP1/DRIL1, an AT-rich interaction domain-family transcription factor, is regulated by p53. Mol. Cancer Res. 2003; 1: 438-444. Ref.: https://goo.gl/c9pZrR

Peeper DS, Shvarts A, Brummelkamp T, Douma S, Koh EY, et al. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence. Nat Cell Biol. 2002; 4:148-153. Ref.: https://goo.gl/8fQDEL

Lin L, Zhou Z, Zheng L, Alber S, Watkins S, et al. Cross talk between Id1 and its interactive protein Dril1 mediate fibroblast responses to transforming growth factor-beta in pulmonary fibrosis. Am J Pathol. 2008; 173: 337-346. Ref.: https://goo.gl/uCbTzr

Zong RT, Tucker PW, Das C. Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies. EMBO J. 2000; 19: 4123-4133. Ref.: https://goo.gl/W31L98

Lin D, Ippolito GC, Zong RT, Bryant J, Koslovsky J, et al. Arid3a/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer. Mol Cancer. 2007; 6: 23. Ref.: https://goo.gl/jAvdqX

Webb CF, Ratliff ML, Powell R, Wirsig-Wiechmann CR, Lakiza O, et al. A developmentally plastic adult mouse kidney cell line spontaneously generates multiple adult kidney structures. Biochem Biophys Res Commun. 2015; 463: 1334-1340. Ref.: https://goo.gl/o3Qa7N

Bosnali M, Münst B, Thier M, Edenhofer F. Deciphering the stem cell machinery as a basis for understanding the molecular mechanism underlying reprogramming. Cell Mol Life Sci. 2009; 66: 3403-3420. Ref.: https://goo.gl/FTXrNa

Chambers I. The Molecular Basis of Pluripotency in Mouse Embryonic Stem Cells. Cloning Stem Cells. 2004; 6, 386-391. Ref.: https://goo.gl/6YBo8d

Kopp JL, Ormsbee BD, Desler M, Rizzino A. Small Increases in the Level of Sox2 Trigger the Differentiation of Mouse Embryonic Stem Cells. STEM CELLS. 2008; 26: 903-911. Ref.: https://goo.gl/zKL2TW

Rhee C, Lee BK, Beck S, Anjum A, Cook KR, et al. Arid3a is essential to execution of the first cell fate decision via direct embryonic and extraembryonic transcriptional regulation. Genes Dev. 2014; 28: 2219-2232. Ref.: https://goo.gl/GV6Bb3

Nagy A. Manipulating the Mouse Embryo: A Laboratory Manual, Third Edition. 2002. Ref.: https://goo.gl/vpdDo1